Side-by-side comparison of AI visibility scores, market position, and capabilities
SF YC W20 preclinical gene therapy for polycystic kidney disease (600K US patients) using AI-driven target identification; $1.1M raised with NIH SBIR grant, raising $4M seed competing with CRISPR Therapeutics for curative kidney genetic medicine.
Nephrogen is a San Francisco-based preclinical gene therapy company — backed by Y Combinator (W20) with $1.1 million in total funding including $775,000 raised to date plus a $325,000 NIH SBIR grant, and currently raising a $4 million seed round with support from StartX and 2048 Ventures — developing curative gene therapies for kidney diseases, with polycystic kidney disease (PKD) as the lead program targeting the 600,000 Americans with the autosomal dominant PKD subtype, an inherited kidney cyst disorder with no disease-modifying treatments that currently progresses to end-stage renal disease requiring dialysis or transplant in the majority of patients. Founded by researchers with combined expertise in AI-driven drug discovery, genetic engineering, and nephrology, Nephrogen applies AI target identification and gene therapy delivery to the largest category of rare inherited kidney diseases.
Nation's largest homebuilder; 89,690 homes FY2024; $36.8B revenue; Express Homes entry-level focus; Forestar vertical land integration; rate buydown strategy sustains demand vs 6%+ mortgages.
D.R. Horton is the nation's largest homebuilder by volume, founded in 1978 by Donald Ray Horton in Fort Worth, Texas and now headquartered in Arlington, Texas, trading on NYSE (DHI). The company delivered approximately 89,690 homes in fiscal year 2024 (ending September 30) and generated $36.8 billion in revenues under CEO Paul Romanowski, who succeeded longtime CEO David Auld in 2024. D.R. Horton operates across 118 markets in 33 states, targeting the broadest range of price points in the industry from entry-level starter homes under the Express Homes brand through core D.R. Horton family homes to luxury properties under Emerald Homes and Freedom Homes age-restricted communities. The company's scale and geographic diversification provide resilience against regional housing market downturns and allow efficient land acquisition across America's fastest-growing metropolitan markets.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.